Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06294-5Source: DataRank Database

Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer is a research paper published in Breast Cancer Research and Treatment (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.81)OA: hybridTopics (43)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Changyuan Guo ORCID,Hela Koka ORCID,Bin Zhu ORCID,Joseph Deng ORCID,Nan Hu ORCID

Live enrichment

PubMed:34185195 PMC:PMC8357643 OpenAlex:https://openalex.org/W3175589744

Division of Cancer Epidemiology and Genetics, National Cancer Institute

FWCI

0.81

Citation Percentile

0.7%

Citation Trend

2021

2022

2024

2025

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s10549-021-06294-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-021-06294-5.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-021-06294-5/fulltext.html

journalhttps://doi.org/10.1007/s10549-021-06294-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34185195

Fields of Study

Cancer Risks and FactorsBreast Cancer Treatment StudiesBreast Lesions and CarcinomasBiomarkers, TumorBreast NeoplasmsFemaleHumansNeoplasm Recurrence, LocalPrognosisErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneRisk Factors

MeSH Terms

Breast NeoplasmsFemaleHumansNeoplasm Recurrence, LocalPrognosisReceptors, EstrogenReceptors, ProgesteroneRisk FactorsBiomarkers, TumorReceptor, ErbB-2Erb-b2 Receptor Tyrosine Kinases

Keywords

MedicineBreast cancerInternal medicineOncologyBody mass indexOdds ratioNottingham Prognostic IndexOverweightConfidence intervalCancerQuartileGynecologyAgePrognosisParityObeseFamily HistoryNpiIhc4

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue

10.6084/m9.figshare.25036290.v1figshare

Additional file 1 of Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue

10.6084/m9.figshare.25036290figshare